Glenmark Pharmaceuticals
GLENMARK.NS
#2590
Rank
S$7.39 B
Marketcap
$26.20
Share price
0.55%
Change (1 day)
104.44%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Total debt

Total debt on the balance sheet as of March 2024 : S$0.19 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's total debt is S$0.19 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Glenmark Pharmaceuticals - Total debt on balance sheet (from 2012 to 2024)

Total debt by year

Year Total debt Change
2023-03-31S$0.74 B5.9%
2022-03-31S$0.70 B-22.72%
2021-03-31S$0.91 B-6.62%
2020-03-31S$0.97 B12.78%
2019-03-31S$0.86 B-7%
2018-03-31S$0.93 B-8.35%
2017-03-31S$1.01 B25.47%
2016-03-31S$0.81 B-2.92%
2015-03-31S$0.83 B21.64%
2014-03-31S$0.68 B8.81%
2013-03-31S$0.63 B13.9%
2012-03-31S$0.55 B-6.92%
2011-03-31S$0.59 B2.08%
2010-03-31S$0.58 B-6.95%
2009-03-31S$0.62 B83.28%
2008-03-31S$0.34 B4.01%
2007-03-31S$0.32 B23.36%
2006-03-31S$0.26 B61.19%
2005-03-31S$0.16 B272.97%
2004-03-31S$44.38 M